Table 3.
Characteristics | n | % | PRa | 95% CI | aPRb | 95% CI |
---|---|---|---|---|---|---|
Retained in Care (N = 151) | ||||||
Age, y | ||||||
18–39 | 94 | 62 | 0.86 | [.70, 1.05] | 0.81 | [.66, 1.00] |
40–49 | 38 | 25 | Ref | … | Ref | … |
50–59 | 17 | 11 | 1.08 | [.86, 1.36] | 1.04 | [.81, 1.32] |
60–69 | 2 | 1 | 1.23 | [1.05, 1.43] | 1.00 | [.78, 1.30] |
≥70 | 0 | 0 | … | … | … | … |
Race/ethnicity | ||||||
White | 33 | 22 | Ref | … | Ref | … |
Black | 61 | 40 | 1.11 | [.85, 1.44] | 1.18 | [.89, 1.56] |
Hispanic | 41 | 27 | 1.08 | [.82, 1.44] | 1.18 | [.88, 1.57] |
Other/Unknown | 16 | 11 | 1.17 | [.84, 1.61] | 1.24 | [.87, 1.76] |
HIV acquisition risk | ||||||
IDU | 5 | 3 | 1.07 | [.69, 1.68] | 1.06 | [.64, 1.77] |
Sexual behavior | 133 | 88 | Ref | … | Ref | … |
Other/Unknown | 13 | 9 | 1.14 | [.88, 1.46] | 1.82 | [1.24, 2.69] |
Suppressed (≤200 copies/mL) HIV Viral Load (N = 173) | ||||||
Age (in years) | ||||||
18–39 | 112 | 65 | 0.86 | [.74, 1.00] | 0.83 | [.72, .96] |
40–49 | 40 | 23 | Ref | … | Ref | … |
50–59 | 19 | 11 | 1.12 | [1.00, 1.25] | 1.14 | [.99, 1.32] |
60–69 | 2 | 1 | 1.12 | [1.00, 1.25] | 1.31 | [.96, 1.80] |
≥70 | … | … | … | … | … | … |
Race/ethnicity | ||||||
White | 35 | 20 | Ref | … | Ref | … |
Black | 76 | 44 | 0.83 | [.69, 1.00] | 0.80 | [.62, 1.03] |
Hispanic | 45 | 26 | 1.06 | [.91, 1.23] | 1.10 | [.94, 1.27] |
Other/Unknown | 17 | 10 | 1.00 | [.81, 1.24] | 0.99 | [.78, 1.27] |
HIV transmission risk | ||||||
IDU | 7 | 4 | 1.05 | [.77, 1.44] | 0.95 | [.69, 1.30] |
Sexual behavior | 152 | 88 | Ref | … | Ref | … |
Other/Unknown | 14 | 8 | 1.14 | [.97, 1.35] | 1.20 | [.83, 1.73] |
Bold signifies the 95% CI does not include 1.0.
Abbreviations: aPR, adjusted prevalence ratio; CI, confidence interval; HIV, human immunodeficiency virus; PR, prevalence ratio; Ref, reference category.
aThe PRs and 95% CIs were estimated using a log-binomial regression model.
bThe aPRs and 95% CIs were estimated using a Poisson regression with robust variance model accounting for age, race/ethnicity, cohort, and HIV risk group.